A pioneering project is to study how myeloma patients feel about receiving information about their genetic risk and their disease’s response to treatment, and understand what support they want.
The project, at University College London, is funded...
5 months ago
Gene editing for patients with severe sickle cell disease is to be made available in the UK, it was announced last week (31st January).
NHS England estimates that around 50 patients a year are expected to receive the treatment, exa-cel (exagamglog...
5 months ago
